BFSG LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$118K Buy
931
+62
+7% +$8.17K 0.01% 350
2026
Q1
$121K Sell
869
-86
-9% -$12K 0.01% 337
2025
Q4
$117K Buy
955
+5
+0.5% +$608 0.01% 323
2025
Q3
$105K Buy
950
+9
+1% +$1.02K 0.01% 334
2025
Q2
$104K Sell
941
-25
-3% -$2.66K 0.01% 319
2025
Q1
$108K Sell
966
-1,742
-64% -$180K 0.01% 302
2024
Q4
$250K Sell
2,708
-1,617
-37% -$146K 0.03% 215
2024
Q3
$363K Sell
4,325
-275
-6% -$21K 0.04% 194
2024
Q2
$316K Buy
4,600
+198
+4% +$13.2K 0.04% 196
2024
Q1
$322K Buy
4,402
+27
+0.6% +$2.08K 0.04% 190
2023
Q4
$354K Sell
4,375
-115
-3% -$8.95K 0.05% 185
2023
Q3
$336K Buy
+4,490
New +$345K 0.05% 186
2022
Q3
Sell
-6,578
Closed -$407K 183
2022
Q2
$407K Buy
+6,578
New +$407K 0.07% 161
2021
Q4
Sell
-2,933
Closed -$202K 224
2021
Q3
$205K Buy
+2,933
New +$206K 0.03% 206
2020
Q3
Sell
-37,954
Closed -$2.92M 193
2020
Q2
$2.92M Sell
37,954
-645
-2% -$49.4K 0.63% 50
2020
Q1
$2.89M Sell
38,599
-5,495
-12% -$380K 0.74% 46
2019
Q4
$2.87M Buy
44,094
+2,340
+6% +$152K 0.54% 63
2019
Q3
$2.57M Buy
+41,754
New +$2.73M 0.57% 60
2018
Q3
Sell
-5,565
Closed -$394K 128
2018
Q2
$394K Hold
5,565
0.17% 112
2018
Q1
$420K Sell
5,565
-615
-10% -$48.9K 0.19% 84
2017
Q4
$443K Sell
6,180
-2,245
-27% -$170K 0.19% 86
2017
Q3
$683K Sell
8,425
-160
-2% -$12.2K 0.31% 74
2017
Q2
$608K Sell
8,585
-1,434
-14% -$95.4K 0.3% 73
2017
Q1
$681K Buy
+10,019
New +$705K 0.34% 74

Other funds holding GILD

BFSG LLC's GILD Position: Q2 2026 in Review

BFSG LLC increased its Gilead Sciences (GILD) stake by 7.1% in Q2 2026, buying an estimated $8.17K and bringing the position to 931 shares worth $118K. The position accounts for 0.01% of the portfolio, ranked #350.

BFSG LLC first reported a position in GILD in Q1 2017 and has held it in 24 quarters since. The position peaked at $2.92M in Q2 2020. 425 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BFSG LLC held 931 shares of Gilead Sciences worth $118K as of Q2 2026.
  • BFSG LLC bought 62 Gilead Sciences shares in Q2 2026, an estimated $8.17K.
  • Gilead Sciences made up 0.01% of BFSG LLC's portfolio in Q2 2026, its #350 holding.
  • BFSG LLC first reported a position in Gilead Sciences in Q1 2017 and has held it in 24 quarters since.
  • BFSG LLC's Gilead Sciences position peaked at $2.92M in Q2 2020.
  • 425 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.